期刊文献+

慢性阻塞性肺疾病治疗策略思考 被引量:8

Thinking about therapeutic strategy of chronic obstructive pulmonary disease
原文传递
导出
摘要 慢性阻塞性肺疾病(COPD)具有气流受限部分可逆特征,系因气道慢性炎症和重构所致,可伴有全身炎症表现和肺外并存疾病。慢性全身性炎症可能导致COPD和并存疾病的共同发病。抗炎治疗亦可作用于全身性炎症和肺外并存疾病,而治疗并存疾病亦有助于COPD的恢复。因此,治疗COPD应同时评估并存疾病,采用综合治疗措施。 Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitation, resulting from chronic airway inflammation and remodeling. It may be associated with systemic inflammatory manifestation and extrapulmonary comorbidities. Chronic systemic inflammation may be the common pathway linking these combiordities. The treatment of COPD inflammation may affect the systemic inflammation and comorbidities simultaneously, and to treat the comorbidities may provide benefit for COPD. Treating patient with COPD should evaluate for associated diseases beyond the lungs, and treating patients with COPD must be a multidimensional approach.
作者 邓伟吾
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2011年第11期801-803,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 肺疾病 慢性阻塞性 全身炎症反应综合征 治疗 肺外并存疾病 pulmonary disease, chronic obstructive systemic inflammatory response syndrome therapy extrapulmonary comorbidities
  • 相关文献

参考文献8

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 2NUSSBAUMER-OCHSNER Y, RABE KF. Systemic manifesta- tions of COPD [J]. Chest, 2011, 139(1 ) : 165-173.
  • 3BARNES PJ, CELLI BR. Systemic manifestations and comor- bidities of COPD[J]. Eur Respir J, 2009, 33(5): 1165-1185.
  • 4FABBRI LM, RABE KF. From COPD to chronic systemic inflammatory syndrome?[J]. Lancet, 2007, 370(9589): 797- 799.
  • 5SIN DD, MAN SF, MARCINIUK DD, et al. The effects of flu- ticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Me~l, 2008, 177(11 ) : 1207-1214.
  • 6POWRIE D J, WILKNSON TM, DONALDSON GC, et aL Effect of tiotropium on sputum and serum inflammatory markers and exacerbation in COPD[J]. Eur Respir J, 2007, 30(3) : 472-478. BARNES PJ. Reduced histone deacetylase in COPD: clinical implications[J]. Chest, 2006, 129(1) : 151-155.
  • 7SIN DD, WU L, MAN SF. The relationship between reduced lung function and cardiovasuclar mortality: a population-based study and a systematic review of the literature[J]. Chest, 2005, 127(6) : 1952-1959.
  • 8MANCINI GB, ETMINAN M, ZHANG B, et ol. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease[J]. J Am Coll Cardiol, 2006, 47(12): 2554-2560.

二级参考文献7

共引文献8239

同被引文献83

引证文献8

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部